On May 11, the World Health Organization ended the mpox global health emergency designation.
A WHO committee discussed concerns surrounding a possible rise in mpox cases on May 10. In a statement, the WHO said it saw “no changes in the severity and clinical manifestation” of mpox while acknowledging “remaining uncertainties about the disease.”
The WHO added that mpox “would be better addressed through sustained efforts in a transition towards a long-term strategy to manage the public health risks … rather than the emergency measures inherent to a public health emergency of international concern.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
